Session 4: Disruptive Technologies: Delivering Innovation to Fermentation
	
					
		
	
		
	Tuesday, November 10, 2015: 8:00 AM-11:30 AM
	Grand Ballroom F-G (Hilton Clearwater Beach Hotel)
	
	
	
	
	
		Convener:
			
				
					
					
						Dorothea Reilly 
						
						  -	Genentech Inc. 	
						
						
					
				
			
 
		Co-Convener:
			
				
					
					
						Supaporn Suwannakham 
						
						  -	DuPont Experimental Station 	
						
						
					
				
			
 
		
		
			8:00 AM
		
	
	
	
		
		
				Transforming fermentation process development with a high-throughput automated bioreactor system
			
R.S. Kuczenski*, Genentech, South San Francisco, CA
				
			
		
	
R.S. Kuczenski*, Genentech, South San Francisco, CA
		
			8:30 AM
		
	
	
	
		
		
				Automated bioreactor sampling – process trigger sampling for enhancing microbial strain engineering and characterization
			
M.J. Maurer*, J.M. Skerker, L. Sutardja, A.L. Muehlbauer, D. Pinel and A.P. Arkin, University of California, Berkeley, Berkeley, CA; W. Miller and M. Biksacky, Flownamics, Inc., Madison, WI; C.M. Huether-Franken and K. Rix, Eppendorf AG, Juelich, Germany
M.J. Maurer*, J.M. Skerker, L. Sutardja, A.L. Muehlbauer, D. Pinel and A.P. Arkin, University of California, Berkeley, Berkeley, CA; W. Miller and M. Biksacky, Flownamics, Inc., Madison, WI; C.M. Huether-Franken and K. Rix, Eppendorf AG, Juelich, Germany
		
			9:00 AM
		
	
	
	
		
		
				Robust, Scalable Standardized Two-Stage Fermentations using Dynamic Metabolic Control
			
M. Lynch*, Z. Ye, D. Rodriguez, A. Trahan, A. Bozdag and G. Kelly, Duke University, Durham, NC
				
			
		
	
M. Lynch*, Z. Ye, D. Rodriguez, A. Trahan, A. Bozdag and G. Kelly, Duke University, Durham, NC
		
			9:30 AM
		
	
	
	
		
		
				Metabolic and genetic switches for stable long-term fermentative production of anabolic products
			
C. Thakker*, Total New Energies USA, Inc., Emeryville, CA
				
			
		
	
C. Thakker*, Total New Energies USA, Inc., Emeryville, CA
		
			10:30 AM
		
	
	
	
		
		
				Production of long chain terminal alcohols through the ‘+1’ pathway: combining enzyme engineering, strain development and fermentation optimization to accelerate development
			
P. Sanghani, E. Shiue, C. Stowers*, M. Devarapalli, P. Bhosale and K. Hill, Dow AgroSciences, Indianapolis, IN; T. Ramseier and N. Mouncey, Dow AgroSciences LLC, Indianapolis, IN; M. Jones, Dow Chemical Compandy, Midland, MI; B. Kolthammer, D. Rosenfeld and A. Arthur, Dow Chemical Company, Freeport, TX
				
			
		
	
P. Sanghani, E. Shiue, C. Stowers*, M. Devarapalli, P. Bhosale and K. Hill, Dow AgroSciences, Indianapolis, IN; T. Ramseier and N. Mouncey, Dow AgroSciences LLC, Indianapolis, IN; M. Jones, Dow Chemical Compandy, Midland, MI; B. Kolthammer, D. Rosenfeld and A. Arthur, Dow Chemical Company, Freeport, TX
		
			11:00 AM
		
	
	
	
		
		
				Cell free protein synthesis platforms capable of manufacturing pipelines of complicated proteins at commercially relevant scales
			
S. Bussell*, Sutro Biopharma, South San Francisco, CA
				
			
		
	
S. Bussell*, Sutro Biopharma, South San Francisco, CA
	
	
	See more of: Invited Papers
	
	
	
	
				